Nurix Therapeutics, Inc. (NRIX) Q2 2026 Earnings Report, Transcript and Summary
Nurix Therapeutics, Inc. (NRIX)
Q2 2026 Earnings Call· Thu, Jul 9, 2026
$23.66
-2.09%
Nurix Therapeutics, Inc. Q2 2026 Earnings Call Key Takeaways
AI summary not available yet
Be the first to generate an AI summary of this earnings call. Takes about 20 seconds, and the result is saved and available to everyone afterwards.
Nurix Therapeutics, Inc. Q2 2026 Revenue and EPS Results
REVENUE
BEAT -43.2%$9M
vs $16M est
−10%est+10%
YoY —·QoQ +44.6%
EPS
MISS -9.5%-$0.81
vs -$0.74 est
−40%est+40%
YoY —·QoQ -2.5%
Stock Price Reaction to Nurix Therapeutics, Inc. Q2 2026 Earnings
Same-Day
-6.60%
1 Week
-6.56%
1 Month
—
vs S&P
—
Nurix Therapeutics, Inc. Q2 2026 Earnings Call Transcript
Transcript not yet available
Earnings call transcripts typically publish within 24 hours of the call. Check back soon — we publish transcripts the moment they're available from our data provider.
Call date: Thursday, July 9, 2026